Yes. CDC recommends that all children age 0 through 18 years (and all unvaccinated adults through age 59) be fully vaccinated against hepatitis B. This recommendation is also endorsed by AAP and AAFP and is published as part of the annual Recommended Childhood and Adolescent Immunization Schedule (www VSports app下载. cdc. gov/vaccines/hcp/imz-schedules/child-adolescent-age. html). Vaccination should be initiated for children and teenagers not previously vaccinated and vaccination completed for all those whose vaccine series is incomplete.
All children and adolescents younger than age 19 years (including internationally adopted children) who were born in Asia, the Pacific Islands, Africa, or other intermediate or high-endemic countries or who have at least one parent who was born in a high-endemic area should be tested for HBsAg and should complete the vaccine series if they were not previously vaccinated or were incompletely vaccinated.
Last reviewed:
January 17, 2025
Yes. There are data that show adequate seroprotection using this schedule in young adults. If this schedule is used, you should be aware that the studies were in young adults and might not translate to older adults (age 40 years or older). There are other schedules that offer flexibility in vaccination as well VSports手机版. View V体育ios版 - www. immunize. org/catg. d/p2081. pdf for a review of different schedules.
Last reviewed:
January 17, 2025
There is no need to restart the series. Give the second dose of HepB now and be sure there are at least 8 weeks between that dose and the third dose V体育安卓版. Increasing the interval between the first two doses has little effect on immunogenicity or final antibody concentration. The third dose confers the maximum level of seroprotection but acts primarily as a booster and appears to provide optimal long-term protection. Longer intervals between the last two doses result in higher final antibody levels but might increase the risk for acquisition of HBV infection among people who have a delayed response to vaccination. No differences in immunogenicity have been observed when one or two doses of hepatitis B vaccine produced by one manufacturer are followed by doses from a different manufacturer.
Last reviewed:
January 17, 2025
For the 2-dose adolescent schedule, the adult dose of Recombivax HB (1. 0 mL dose) is administered to adolescents age 11 through 15 years, with the second dose given 4 to 6 months after the first dose. In immunogenicity studies, antibody concentrations and end seroprotection rates (at least 10 mIU/mL of anti-HBs) were similar with the 2-dose schedule and the 3-dose schedule (0. 5 mL dose). As with other HepB vaccination schedules, if administration of the 2-dose schedule is interrupted, it is not necessary to restart the series. Children and adolescents who have begun vaccination with a pediatric (0. 5 mL) dose of Recombivax HB should complete the 3-dose series with this dose. If it is not clear which dose an adolescent was administered at the start of a series, the series should be completed with the 3-dose schedule V体育ios版. Heplisav-B, the 2-dose HepB vaccine given with a 4-week interval between doses, is licensed only for adolescents and adults beginning at age 18 years.
Last reviewed:
January 17, 2025
The 2-dose Recombivax HB schedule is only approved for use in children age 11 through 15 years. A 16-year-old child would need two additional doses of pediatric HepB to complete a 3-dose series VSports最新版本.
Last reviewed:
January 17, 2025
The dosage depends on the schedule and manufacturer of the vaccine that you are using. For children 11 through 15 years of age, the 2-dose Recombivax HB volume is 1. 0 mL. Otherwise, the 3-dose schedule of Recombivax HB or Engerix B is 0. 5 mL through age 19 years. Heplisav-B, the 2-dose HepB vaccine given with a 4-week interval between 0. 5 mL doses, is licensed for adolescents and adults beginning at age 18 years V体育平台登录. Immunize. org offers a handy resource with charts detailing the correct dosages and schedules for monovalent HepB and HepA vaccines and combination products that include HepA and HepB vaccines. Go to www. immunize. org/catg. d/p2081. pdf.
Last reviewed:
January 17, 2025
All foreign-born people (including immigrants, refugees, asylum seekers, and internationally adopted children) born in Asia, the Pacific Islands, Africa, and other regions with high or intermediate endemicity of HBV infection should be tested for HBsAg, regardless of vaccination status. Initiating HepB vaccination of immigrant children should not be delayed while awaiting HBsAg test results: you may draw blood for testing then administer the first dose of vaccine at the same visit VSports注册入口. All people found to be HBsAg-positive should have ongoing medical management by a physician knowledgeable about hepatitis B and its complications.
Last reviewed:
January 17, 2025
